Clinical evaluation of Hareethaki(Terminalia chebula Retz) choorna in Non Alcoholic Fatty Liver Disease

Clinical evaluation of Hareethaki (Terminalia chebula Retz.) choorna in Non Alcoholic Fatty Liver Disease - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076728

Enrollment

Registered

2024-11-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E889- Metabolic disorder, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals from 30 to 60 years of age of either sex 2.Patient with NAFLD with mild & moderate fatty infiltration (Grade 1 & 2 )

Exclusion criteria

Exclusion criteria: 1.Estimated average alcohol consumption greater than 20ml/day for men or greater than 10 ml/day for women in the six months prior to enrolment. 2.Patient with known cases of viral,metabolic or other specific etiologies of liver disease,liver transplant,liver cirrhosis,uncontrolled diabetes mellitus,coronary artery disease,congestive heart failure,chronic kidney disease,malignancies. 3.Patient undergone gastrointestinal surgery 4.Patients on treatment with medications known to cause fattyliver disease such as atypical neuroleptics,glucocorticoids,aspirin,tetracycline,methotrexate or tamoxifen,synthetic oestrogens,amiodarone,calcium channel blockers. 5.Increased conditions of Pitta dosha 6.Pregnant and lactacting women 7.Patients not willing to give consent

Design outcomes

Primary

Measure	Time frame
To clinically evaluate Hareethaki (Terminalia chebula Retz.)choorna in Non Alcoholic Fatty Liver Disease(NAFLD)Timepoint: Patients will be assessed before and after the intervention. Initially patient will be assessed by USG and NAFLD Fibrosis Score.Medication will be provided for 30 days and followup will be done for the next 15 days without intervention and data will be collected.	—

Secondary

Measure	Time frame
To study Hareethaki (Terminalia chebula Retz.) pharmacognostically & phytochemicallyTimepoint: Pharmacognostical assessment of Hareethaki will be done within 1 year	—

Countries

India

Contacts

Public ContactDr Shincymol V V

Government Ayurveda College Tripunithura

vvshincymol@gmail.com9947012863

Outcome results